Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Cancer Imaging and Image-directed Interventions

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1591858

This article is part of the Research TopicAI-Powered Insights: Predicting Treatment Response and Prognosis in Breast CancerView all 7 articles

Construction of a Prediction Model for Axillary Lymph Node Metastasis in Breast Cancer Patients Based on a Multimodal Fusion Strategy of Ultrasound and Pathological Images

Provisionally accepted
Lingli  PengLingli Peng1Lan  YuLan Yu2Beibei  LiuBeibei Liu1feixiang  xiangfeixiang xiang1*Yu  WuYu Wu1*
  • 1Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan, China
  • 2Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan, China

The final, formatted version of the article will be published soon.

Background: Accurate assessment of axillary lymph node status is essential for the management of breast cancer. Recent advancements in deep learning (DL) have shown promising results in medical image analysis. This study aims to develop a multimodal DL model that integrates preoperative ultrasound images and hematoxylin and eosin (H&E)-stained core needle biopsy pathology images of primary breast cancer to predict axillary lymph node metastasis (ALNM).This study included 211 patients with histologically confirmed breast cancer, conducted between February 2023 and March 2024. For each patient, one ultrasound image and one histopathological image of the primary breast cancer lesion were collected. Various DL architectures were applied to extract tumor features from the ultrasound and histopathology images, respectively. Multiple fusion strategies, combining features from both ultrasound and pathology images, were developed to enhance the comprehensiveness and accuracy of predictions. The performance of the single-modality models, multi-modality models, and different fusion strategies were compared. Evaluation metrics included precision, accuracy, recall, F1-score, and area under the curve (AUC).Results: PLNeT and ULNet were identified as the most effective feature extractors for histopathological and ultrasound image analysis, respectively. Overall, the multilayer fusion model outperformed single-modality models in predicting ALNM, achieving an accuracy of 0.7353, precision of 0.7344, recall of 0.7576, F1-score of 0.7463, and AUC of 0.7019.Our study provides a multilayer fusion strategy using ultrasound and pathology images of the primary tumor to predict ALNM in breast cancer patients.Although achieving suboptimal performance, this model has the potential to determine appropriate axillary treatment options for patients with breast cancer.

Keywords: breast cancer, deep learning, Axillary lymph node metastasis, ultrasound, Core-needle biopsy

Received: 14 Mar 2025; Accepted: 12 Aug 2025.

Copyright: © 2025 Peng, Yu, Liu, xiang and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
feixiang xiang, Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan, China
Yu Wu, Department of Ultrasound, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.